Nestin+ kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury
Source abstract
Abstract
Renal resident mesenchymal stem cells (MSCs) are important regulators of kidney homeostasis, repair or regeneration. However, natural distribution and the starting population properties of these cells remain elusive because of the lack of specific markers. Here, we identified post-natal kidney derived Nestin(+) cells that fulfilled all of the criteria as a mesenchymal stem cell. These isolated Nestin(+) cells expressed the typical cell-surface marker of MSC, including Sca-1, CD44, CD106, NG2 and PDGFR-α. They were capable of self-renewal, possessed high clonogenic potential and extensive proliferation for more than 30 passages. Under appropriate differentiation conditions, these cells could differentiate into adipocytes, osteocytes, chondrocytes and podocytes. After intravenous injection into acute kidney injury mice, Nestin(+) cells contributed to functional improvement by significantly decreasing the peak level of serum creatinine and BUN, and reducing the damaged cell apoptosis. Furthermore, conditioned medium from Nestin(+) cells could protect against ischemic acute renal failure partially through paracrine factor VEGF. Taken together, our findings indicate that renal resident Nestin(+) MSCs can be derived, propagated, differentiated, and repair the acute kidney injury, which may shed new light on understanding MSCs biology and developing cell replacement therapies for kidney disease.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesenchymal stem cell research · Tissue Engineering and Regenerative Medicine · Renal and related cancers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Mesenchymal stem cells: revisiting history, concepts, and assays10.1016/j.stem.2008.03.002 ↗
2. Immunomodulatory properties of mesenchymal stromal cells10.1182/blood-2007-02-069716 ↗
3. Mesenchymal stem cell interactions with growth factors on kidney repair10.1097/MNH.0b013e328333062c ↗
4. Induction therapy with autologous mesenchymalstem cells in living-related kidney transplants: a randomizedcontrolled trial10.1001/jama.2012.316 ↗
5. Insulin-like growth factor-1 sustains stem cell mediated renal repair10.1681/ASN.2006121318 ↗
6. Protective actions of administrated mesenchymal stem cells in acute kidney injury: relevance to clinical trials10.1038/kisup.2011.24 ↗
7. Mesenchymal stem cells reside in virtually all post-natal organs and tissues10.1242/jcs.02932 ↗
8. Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despits maintenance of distinct identities10.1016/j.scr.2011.08.003 ↗
9. Isolation and characterization of resident mesenchymal stem cells in human glomeruli10.1089/scd.2008.0320 ↗
10. The potential for resident lung mesenchymal stem cells to promote functional tissue regeneration: understanding microenvironmental cues10.3390/cells1040874 ↗
11. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow10.1002/stem.139 ↗
12. Phenotypic and functional heterogeneity of human bone marrow – and amnion-derived MSC subsets10.1111/j.1749-6632.2012.06551.x ↗
13. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor10.1038/347762a0 ↗
14. Nestin expression-a property of multi-lineage progenitor cells?10.1007/s00018-004-4144-6 ↗
15. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche10.1038/nature09262 ↗
16. Nestin expression in adult and developing human kidney10.1369/jhc.6A7058.2007 ↗
17. Nestin expression in repopulating mesangial cells promotes their proliferation10.1038/labinvest.2008.5 ↗
18. Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes10.1681/ASN.2005101032 ↗
19. Normal distribution and medullary-to-cortical shift of nestin-expressing cells in acute renal ischemia10.1038/sj.ki.5002102 ↗
20. Upregulation of nestin in proximal tubules may participate in cell migration during renal repair10.1152/ajprenal.00083.2012 ↗
21. Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice10.1097/00001756-200006260-00037 ↗
22. Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells10.1016/j.biocel.2013.07.015 ↗
23. The isolation and in situ identification of MSCs residing in loose connective tissues using aniche-preserving organ culture system10.1016/j.biomaterials.2012.03.009 ↗
24. Protecting against wayward human induced pluripotent stem cells with a suicide gene10.1016/j.biomaterials.2012.01.023 ↗
25. C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential10.1002/stem.1412 ↗
26. Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice10.1681/ASN.2006050424 ↗
27. PDGFRα and CD51 mark human nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion10.1084/jem.20122252 ↗
28. Concise review: mesenchymal stem cell treatment for ischemic kidney disease10.1002/stem.1449 ↗
29. Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury10.1016/j.jcyt.2013.07.017 ↗
30. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury10.1152/ajprenal.00339.2006 ↗
31. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury10.1681/ASN.2008070798 ↗
32. Osteogenesis in transplants of bone marrow cells
33. Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue10.1016/j.vetimm.2009.06.014 ↗
34. Adult cardiac-resident MSC-like stem cells with a proepicardial origin10.1016/j.stem.2011.10.002 ↗
35. Isolation of the multipotent MSC subpopulation from human gingival fibroblasts by culturing on chitosan membranes10.1016/j.biomaterials.2011.12.032 ↗
36. Mesenchymal progenitor cells from canine fetal tissues: yolk sac, liver, and bone marrow10.1089/ten.tea.2010.0678 ↗
37. Isolation of mesenchymal stem cells using the total length of umbilical cord for transplantation purposes10.1111/j.1365-3148.2011.01076.x ↗
38. Adult renal mesenchymal stem cell-like cells adult renal mesenchymal stem cell-like cells10.1681/ASN.2012060596 ↗
39. Assessing the potential of colony morphology for dissecting the CFU-F population from human bone marrow stromal cells10.1007/s00441-013-1564-3 ↗
40. Concerted regulation of CD34 and CD105 accompanies mesenchymal stromal cell derivation from human adventitial stromal cell10.1089/scd.2012.0263 ↗
41. Bühring HJ. Prospective isolation of human MSC10.1016/j.beha.2011.01.001 ↗
42. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region10.2350/11-01-0959-OA.1 ↗
43. Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells10.1089/ten.tea.2012.0649 ↗
44. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney10.1242/dev.02184 ↗
45. Nestin expression in the kidney with an obstructed ureter10.1038/sj.ki.5002277 ↗
46. Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: a new look at an old model10.1152/ajprenal.00022.2011 ↗
47. Expression of nestin in the podocytes of normal and diseased human kidneys10.1152/ajpregu.00319.2006 ↗
48. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury10.1007/s00428-005-0134-9 ↗
49. Stromal cells protect against acute tubular injury via an endocrine effect10.1681/ASN.2007020140 ↗
50. Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms10.1016/j.yexmp.2013.03.002 ↗
51. VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury10.1111/j.1582-4934.2008.00641.x ↗
52. Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury10.1038/ki.2013.102 ↗
53. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF10.1681/ASN.2004010067 ↗
54. Vascular endothelial growth factor induces branching morphogenesis/tubulogenesis in renal epithelial cells in a neuropilin-dependent fashion10.1128/MCB.25.17.7441-7448.2005 ↗
55. Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury10.1089/scd.2008.0092 ↗